Søgeresultater - Li-Qing Kang

Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report af Ze-Fa Liu, Li-Yun Chen, Jin Wang, Li-qing Kang, Hua Tang, Yao Zhou, Hai-Xia Zhou, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue

Få fuldtekst

Successful application of anti-CD19 CAR-T therapy with IL-6 knocking down to patients with central nervous system B-cell acute lymphocytic leukemia af Li-Yun Chen, Li-Qing Kang, Hai-Xia Zhou, Han-Qing Gao, Xue-Fei Zhu, Nan Xu, Lei Yu, De-Pei Wu, Sheng-Li Xue, Ai-Ning Sun

Få fuldtekst

CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL af Hai-ping Dai, Dan-qing Kong, Hong-jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-qing Kang, Lei Yu, De-pei Wu, Xiao-wen Tang

Få fuldtekst

Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transpla... af Meng-Yun Li, Zhi-Hong Lin, Ming-Ming Hu, Li-Qing Kang, Xiao-xia Wu, Qi-wei Chen, Xin Kong, Jian Zhang, Hui-Ying Qiu, De-Pei Wu

Få fuldtekst

CD19 CAR-T in relapsed t(8;21) AML: a single-center prospective phase II clinical trial af Jia Yin, Qing-Ya Cui, Hai-Ping Dai, Chang-Ju Qu, Zheng Li, Li-Qing Kang, Wei Cui, Xiao-Peng Tian, Xia-Ming Zhu, Lei Yu, De-Pei Wu, Xiao-Wen Tang

Få fuldtekst

Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL af Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue

Få fuldtekst

Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19... af Wen-Jie Gong, Wen-Jie Gong, Yan Qiu, Yan Qiu, Ming-Hao Li, Ming-Hao Li, Li-Yun Chen, Li-Yun Chen, Yan-Yan Li, Yan-Yan Li, Jing-Qiu Yu, Jing-Qiu Yu, Li-Qing Kang, Ai-Ning Sun, Ai-Ning Sun, De-Pei Wu, De-Pei Wu, Lei Yu, Lei Yu, Sheng-Li Xue, Sheng-Li Xue

Få fuldtekst

Safe and potent anti‐CD19 CAR T‐cells with shRNA‐IL‐6 gene silencing element in patients with refractory or relapsed B‐cell acute lymphoblastic leukemia af Jin‐Feng Ma, Jia‐Wei Yan, Mei‐Jing Liu, Chun‐Long Yan, Xiao‐Wen Tang, Hui‐Ying Qiu, Miao Miao, Yue Han, Li‐Min Li, Li‐Qing Kang, Nan Xu, Zhou Yu, Jing‐Wen Tan, Hong‐Jia Zhu, Xu Jia, Zhi‐Zhi Zhang, Miao Wang, Hai‐Ping Dai, Lei Yu, Sheng‐Li Xue, De‐Pei Wu, Wen‐Jie Gong

Få fuldtekst

IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial af Sheng-Li Xue, Mei-Jing Liu, Chong-Sheng Qian, Su-Ning Chen, Hui-Ying Qiu, Li-Qing Kang, Hai-Ping Dai, Wen-Jie Gong, Li-Yun Chen, Zhen Yao, Ming-Zhu Xu, Hai-Xia Zhou, Xiao-Fei Yang, Qian Wu, Xue-Qing Dou, Jian Zhang, Yin Liu, Qing-Ya Cui, Zheng Li, Yang Xu, Man Qiao, Tong-Tong Zhang, Jing-Wen Tan, Nan Xu, Ming-Hao Li, Zhou Yu, Xiao-Yan Lou, Wei Wang, Hong-Jia Zhu, Lu Qin, Lei Yu, Xiao-Wen Tang, De-Pei Wu

Få fuldtekst